-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Short Interest in Centogene (NASDAQ:CNTG) Drops By 20.1%
Short Interest in Centogene (NASDAQ:CNTG) Drops By 20.1%
Centogene (NASDAQ:CNTG – Get Rating) was the target of a significant decrease in short interest in the month of July. As of July 15th, there was short interest totalling 18,700 shares, a decrease of 20.1% from the June 30th total of 23,400 shares. Approximately 0.3% of the company's shares are sold short. Based on an average daily volume of 9,600 shares, the short-interest ratio is currently 1.9 days.
Centogene Stock Performance
NASDAQ CNTG opened at $1.55 on Thursday. The company has a market capitalization of $30.78 million, a price-to-earnings ratio of -0.64 and a beta of -1.18. Centogene has a twelve month low of $1.34 and a twelve month high of $11.61. The stock has a fifty day simple moving average of $2.24 and a 200 day simple moving average of $3.30. The company has a quick ratio of 2.41, a current ratio of 2.48 and a debt-to-equity ratio of 0.67.
Get Centogene alerts:Centogene (NASDAQ:CNTG – Get Rating) last issued its quarterly earnings results on Friday, July 15th. The company reported ($0.54) earnings per share for the quarter. Centogene had a negative return on equity of 134.55% and a negative net margin of 35.35%. The business had revenue of $11.59 million for the quarter. Sell-side analysts expect that Centogene will post -1.72 EPS for the current year.
Institutional Trading of Centogene
An institutional investor recently bought a new position in Centogene stock. DekaBank Deutsche Girozentrale bought a new stake in Centogene (NASDAQ:CNTG – Get Rating) in the 1st quarter, according to its most recent 13F filing with the SEC. The firm bought 16,319 shares of the company's stock, valued at approximately $67,000. DekaBank Deutsche Girozentrale owned 0.08% of Centogene at the end of the most recent reporting period.Analyst Ratings Changes
Separately, SVB Leerink decreased their price objective on Centogene from $10.00 to $6.00 and set an "outperform" rating for the company in a report on Monday, July 18th.
Centogene Company Profile
(Get Rating)
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing.
Read More
- Get a free copy of the StockNews.com research report on Centogene (CNTG)
- There Are Different Types of Stock To Invest In
- Is it Time to Tap Molson Coors or Will Beer Sales Turn Flat?
- Is Starbucks Shooting For The Moon?
- PayPal Continues To Struggle As Competition Increases
- Two High-Yield Deep-Values You Shouldn't Ignore
Receive News & Ratings for Centogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centogene and related companies with MarketBeat.com's FREE daily email newsletter.
Centogene (NASDAQ:CNTG – Get Rating) was the target of a significant decrease in short interest in the month of July. As of July 15th, there was short interest totalling 18,700 shares, a decrease of 20.1% from the June 30th total of 23,400 shares. Approximately 0.3% of the company's shares are sold short. Based on an average daily volume of 9,600 shares, the short-interest ratio is currently 1.9 days.
Centogene(纳斯达克:CNTG-GET Rating)是空头股数7月份大幅下降的目标。截至7月15日,空头股数共有18,700股,较6月30日的23,400股减少20.1%。该公司约0.3%的股票被卖空。以日均成交量9,600股计算,短息比率目前为1.9天。
Centogene Stock Performance
世纪之交股票表现
NASDAQ CNTG opened at $1.55 on Thursday. The company has a market capitalization of $30.78 million, a price-to-earnings ratio of -0.64 and a beta of -1.18. Centogene has a twelve month low of $1.34 and a twelve month high of $11.61. The stock has a fifty day simple moving average of $2.24 and a 200 day simple moving average of $3.30. The company has a quick ratio of 2.41, a current ratio of 2.48 and a debt-to-equity ratio of 0.67.
新浪纳斯达克周四开盘价为1.55美元。该公司市值为3,078万美元,市盈率为-0.64倍,贝塔系数为-1.18。Centogene的12个月低点为1.34美元,12个月高位为11.61美元。该股的50日简单移动均线为2.24美元,200日简单移动均线为3.30美元。该公司的速动比率为2.41,流动比率为2.48,债务权益比率为0.67。
Centogene (NASDAQ:CNTG – Get Rating) last issued its quarterly earnings results on Friday, July 15th. The company reported ($0.54) earnings per share for the quarter. Centogene had a negative return on equity of 134.55% and a negative net margin of 35.35%. The business had revenue of $11.59 million for the quarter. Sell-side analysts expect that Centogene will post -1.72 EPS for the current year.
Centogene(纳斯达克:CNTG-GET Rating)上一次发布季度收益报告是在7月15日(星期五)。该公司公布了本季度每股收益(0.54美元)。Centogene的净资产回报率为负134.55%,净利润率为负35.35%。该业务本季度的收入为1159万美元。卖方分析师预计,Centogene本年度每股收益将达到1.72欧元。
Institutional Trading of Centogene
世纪之交的机构交易
Analyst Ratings Changes
分析师评级发生变化
Separately, SVB Leerink decreased their price objective on Centogene from $10.00 to $6.00 and set an "outperform" rating for the company in a report on Monday, July 18th.
另外,SVB Leerink在7月18日周一的一份报告中将Centogene的目标价从10.00美元下调至6.00美元,并为该公司设定了“跑赢大盘”的评级。
Centogene Company Profile
Centogene公司简介
(Get Rating)
(获取评级)
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing.
Centogene N.V.及其子公司专注于罕见疾病,将现实世界的临床和基因或其他数据转换为可操作的信息,供世界各地的患者、医生和制药公司使用。它通过三个部门运作:制药、诊断和新冠肺炎测试。
Read More
阅读更多内容
- Get a free copy of the StockNews.com research report on Centogene (CNTG)
- There Are Different Types of Stock To Invest In
- Is it Time to Tap Molson Coors or Will Beer Sales Turn Flat?
- Is Starbucks Shooting For The Moon?
- PayPal Continues To Struggle As Competition Increases
- Two High-Yield Deep-Values You Shouldn't Ignore
- 免费获取StockNews.com关于Centogene的研究报告(CNTG)
- 有不同类型的股票可供投资
- 是时候开发Molson Coors了,还是啤酒销售会变得平淡?
- 星巴克是在向月球进军吗?
- PayPal继续挣扎,竞争加剧
- 你不应该忽视的两个高收益深度价值
Receive News & Ratings for Centogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centogene and related companies with MarketBeat.com's FREE daily email newsletter.
接受《世纪英文报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Centogene和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧